Related Experiment Video
Updated: Jul 13, 2026

Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies
Published on: January 16, 2019
Imaging patients with chronic kidney disease: CIN or NSF?
Patients with chronic kidney disease (CKD) need contrast imaging. Both iodinated and gadolinium contrast agents pose risks, necessitating careful selection to avoid kidney damage like contrast-induced nephropathy (CIN) or nephrogenic systemic fibrosis (NSF).
Area of Science:
- Radiology and Nephrology
- Medical Imaging Safety
Background:
- Patients with chronic kidney disease (CKD) often require contrast-enhanced imaging for management.
- Historically, magnetic resonance (MR) imaging with gadolinium (Gd)-based contrast agents was preferred over computed tomography (CT) with iodinated contrast media (CM) due to concerns about iodinated CM-induced nephropathy (CIN).
Discussion:
- Recent findings link Gd-based contrast agents to nephrogenic systemic fibrosis (NSF), a severe reaction in patients with moderate-to-severe renal insufficiency.
- This places CKD patients at risk for both CIN and NSF, complicating imaging modality selection.
Key Insights:
- Understanding the risk factors for both CIN and NSF is crucial for optimizing patient outcomes in CKD.
- Radiologists must balance the benefits of contrast-enhanced imaging against the potential risks of contrast media in renal impairment.
Outlook:
- Further research into safer contrast agents and risk stratification protocols for CKD patients is warranted.
- Developing guidelines for appropriate contrast agent selection based on individual patient renal function is essential for patient safety.
Related Concept Videos
Imaging Studies VII: Vascular Imaging
Imaging Studies II: Ultrasonography
Chronic Kidney Disease III: Interprofessional Care
Imaging Studies III: Computed Tomography
Imaging Studies I: Kidney, Ureter, and Bladder Studies
Imaging Studies IV: Magnetic Resonance Imaging

